Skip to main content

Milestone 9.N

ADRD Specific Milestone

Determining the value of screening for clinically relevant cognitive impairment in the absence of a cognitive complaint.


Success Criteria

  • Complete at least one practical trial of iterative (over time) cognitive impairment screening that determines the value of performing an initial cognitive assessment in middle adulthood that can serve as a baseline for future determination of meaningful change in cognitive function (a sort of “Brain Health Check” and baseline). Measure the effects that positive screenings have on the individual, family, health care system, and health care provider decision making. Complete at least one practical trial of iterative (over time) cognitive impairment screening on health disparities populations, starting during midlife, to determine the value of cognitive screening in underserved communities.


Research Implementation Area
Biomarkers
Timeline
2022–2025
Status
To Be Initiated

Relevant Recommendations